NasdaqGM - Delayed Quote USD
AB Corporate Bond ETF (EYEG)
35.41 +0.16 (+0.45%)
At close: June 24 at 4:00:00 PM EDT
36.21 +0.81 (+2.27%)
After hours: June 24 at 7:44:18 PM EDT
Trade EYEG on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for EYEG
- Previous Close
35.24 - Open
35.40 - Bid --
- Ask --
- Day's Range
35.40 - 35.40 - 52 Week Range
34.82 - 36.63 - Volume
291 - Avg. Volume
220 - Net Assets 26.54M
- NAV 35.23
- PE Ratio (TTM) --
- Yield 4.94%
- YTD Daily Total Return 0.51%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 0.30%
Performance Overview
View MoreTrailing returns as of 6/23/2026. Category is Corporate Bond.
Related ETF News
View More
Research Reports
View MoreWhat does Argus have to say about NEO?
NEOGENOMICS INC has an Investment Rating of HOLD; a target price of $52.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $52.00
NEOGENOMICS INC has an Investment Rating of HOLD; a target price of $52.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $50.00
NEOGENOMICS INC has an Investment Rating of HOLD; a target price of $50.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetWhat does Argus have to say about VNDA?
VANDA PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $15.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target
Related Tickers
XHB State Street SPDR S&P Homebuilders ETF
114.28 +5.62%
FBT First Trust NYSE Arca Biotechnology Index Fund
237.29 +2.90%
PKB Invesco Building & Construction ETF
111.79 +2.62%
AGNG Global X Aging Population ETF
35.43 +1.69%
PSCI Invesco S&P SmallCap Industrials ETF
180.66 +1.64%
FTXH First Trust Nasdaq Pharmaceuticals ETF
36.78 +1.52%
FDIS Fidelity MSCI Consumer Discretionary Index ETF
100.70 +1.36%
RWJ Invesco S&P SmallCap 600 Revenue ETF
58.42 +1.35%
IYC iShares US Consumer Discretionary ETF
100.65 +1.32%
VCR Vanguard Consumer Discretionary Index Fund ETF Shares
388.01 +1.32%
XSVM Invesco S&P SmallCap Value with Momentum ETF
69.37 +1.31%
PTH Invesco Dorsey Wright Healthcare Momentum ETF
55.65 +1.29%
RTH VanEck Retail ETF
257.99 +1.27%
RZV Invesco S&P SmallCap 600 Pure Value ETF
144.55 +1.27%
FYX First Trust Small Cap Core AlphaDEX Fund
140.19 +1.26%
ETHO Amplify Etho Climate Leadership U.S. ETF
77.84 +1.20%